Advanced electrochemical nanobiosensor for ultraefficient Annexin A2 biomarker detection: A rapid, label free and minimal invasive approach towards early diagnosis …

D Chauhan, R Chandra, S Kumar - Materials Letters, 2021 - Elsevier
Abstract Annexin A2 (ANXA2) is a highly specific and sensitive biomarker with high
diagnostic accuracy, secreted in serum of liver cancer (LC) patients with an optimum cut-off …

[HTML][HTML] Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma

SA Badr, MW Fahmi, MM Nomir… - Cancer biology & …, 2018 - ncbi.nlm.nih.gov
Objective: Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide.
The identification of new simple, inexpensive and highly accurate markers for HCC …

Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients

AA Seif, HH Aly, DM Elzoghby, AM Elbreedy… - Egyptian Journal of …, 2019 - Springer
Background Alpha-fetoprotein (AFP) is currently used for serologic screening in
hepatocellular carcinoma (HCC) but with low sensitivity ranging 41–65% with a high rate of …

A Review on Serum, Genetic and Mirna Associated Biomarkers for The Early Diagnosis of Hepatocellular Carcinoma (HCC)

A Kanwal, A Tayyeb - Journal of Bioresource …, 2022 - corescholar.libraries.wright.edu
Hepatocellular carcinoma is the most devastating complication of liver cirrhosis and
diagnosis in earlier stages could be useful in curative interventions. The main aim of this …

Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients

AEFF Hanno, FM Abd El-Aziz, AA Deghady… - Egyptian Liver …, 2019 - Springer
Background Liver cancer is the fifth most common cancer and the second most frequent
cause of cancer-related death globally. Early stages of hepatocellular carcinoma (0&A) can …